Member Info for Rocket79

Upcoming news flow for: #GDR

Beckman validation
Beckman partnership & orders
Euro sales news
Full FDA approval
WHO approval
India Approval
Divoc deal
PoC device launch and CE mark
U.K. tender
US DoD contract to be signed
Launch of hearing loss kit
Hep C kit

Upcoming news flow for: #GDR

Beckman validation
Beckman partnership & orders
Euro sales news
Full FDA approval
WHO approval
India Approval
Divoc deal
PoC device launch and CE mark
U.K. tender
US DoD contract to be signed
Launch of hearing loss kit
Hep C kit

STRONG BUY

Good luck all holders. Remember Genedrive is not just a covid play. Strong Buy

This is going to rerate on news. Massive buying volume today as investors get in before news.Plenty of news due Q1.

Plenty of news due Q1. Exciting times. This will catch up NCYT which is above £10 a share now.

I did my research on Avacta (AVCT), Novacyte (NCYT), Omega Diagnostics (ODX), genedrive (GDR).

1 - Genedrive - 26.54 - 1.06M - the Best opportunity - No orders - waiting for approval - still low - multibagger
2 - Omega - 212.26 - 8.51M I already have a position. - No orders - waiting for approval
3 Avacta - 376.45 - 3.20M - Price Too high & MC too high - No orders - waiting for approval
4 Novacyt - 794.78 - TBC - Too high for me

Https://www.pharmiweb.com/press-release/2021-01-21/covid-19-testing-sector-demand-set-to-continue-amid-vaccine-rollout

POC results imminent. This is going to rerate

I did my research on Avacta (AVCT), Novacyte (NCYT), Omega Diagnostics (ODX), genedrive (GDR).

1 - Genedrive - 26.54 - 1.06M - the Best opportunity - No orders - waiting for approval - still low - multibagger
2 - Omega - 212.26 - 8.51M I already have a position. - No orders - waiting for approval
3 Avacta - 376.45 - 3.20M - Price Too high & MC too high - No orders - waiting for approval
4 Novacyt - 794.78 - TBC - Too high for me

Https://www.pharmiweb.com/press-release/2021-01-21/covid-19-testing-sector-demand-set-to-continue-amid-vaccine-rollout

This is the beats the competition hands down imo. Exciting times ahead and plenty of next in Q1. This will multibag in next few months first target 500p by May and over 1000p end of yr

Official we are distributing in the US now. Strong Buy. 500p by June imo

Even at 500p Genedrive would still be cheap with a mcap below 400m. Bring on the news in Q1

GDR test has advantages with its bead technology. Once we get regulatory clearance in key markets this will rerate.

My target is £10 a share in 2021. Good work.

Fantastic news this will be over £10 a share 2021. STRONG BUY

Off topic but Saga is a Strong Buy. Rejected takeover 480p and will be £10 a share 2021. Currently only 300p. Saga has a cruise business but current share price is fully underwritten by insurance business. Dyor

480p takeover rejected when Covid vaccine was not proved to work. This will be £10 a share easy next year. Now rumours of Carnival eyeing up a bid @£7

Fantastic opportunity here over next 12 months. This will be trading about £10 a share first half next year and could possible reach £20 a share by 2022 imo

Ridiculously undervalued once cruises start again these will be £10 in 12 months imo. Insurance business alone is worth more than current mcap.

You are forgetting to add on the £150mil raised. Puts Saga in a much stronger position

Vaccine news in November and these will blast through the 300p level. These are ridiculously undervalued. Good luck